Klearman Micki 4
4 · Kezar Life Sciences, Inc. · Filed Jun 30, 2021
Insider Transaction Report
Form 4
Klearman Micki
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-28+26,000→ 26,000 totalExercise: $5.59Exp: 2031-06-27→ Common Stock (26,000 underlying)
Footnotes (1)
- [F1]One-hundred percent (100%) of the shares subject to the option shall vest on 6/28/2022, subject to Reporting Person continuing to provide service through such date.